Evidence map›Paper›PMID 41048929›Full record

ArticleFrontiers in medicine2025

Management of severe pneumonia in respiratory non-intensive care unit: a retrospective study from a single center experience.

Lucrezia Pisanu, Marianna Russo, Maria Arminio, Lorenzo Arlando, Valentina Conio, Francesco Rocco Bertuccio, Klodjana Mucaj, Mitela Tafa, Giulia Maria Stella, Angelo Guido Corsico

Abstract read
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Lucrezia PisanuCardiothoracic and Vascular Department, Unit of Respiratory Diseases, IRCCS Policlinico San Matteo Foundation, Pavia, Italy.
Marianna RussoCardiothoracic and Vascular Department, Unit of Respiratory Diseases, IRCCS Policlinico San Matteo Foundation, Pavia, Italy.
Maria ArminioCardiothoracic and Vascular Department, Unit of Respiratory Diseases, IRCCS Policlinico San Matteo Foundation, Pavia, Italy.
Lorenzo ArlandoCardiothoracic and Vascular Department, Unit of Respiratory Diseases, IRCCS Policlinico San Matteo Foundation, Pavia, Italy.
Valentina ConioCardiothoracic and Vascular Department, Unit of Respiratory Diseases, IRCCS Policlinico San Matteo Foundation, Pavia, Italy.
Francesco Rocco BertuccioCardiothoracic and Vascular Department, Unit of Respiratory Diseases, IRCCS Policlinico San Matteo Foundation, Pavia, Italy.
Klodjana MucajCardiothoracic and Vascular Department, Unit of Respiratory Diseases, IRCCS Policlinico San Matteo Foundation, Pavia, Italy.
Mitela TafaCardiothoracic and Vascular Department, Unit of Respiratory Diseases, IRCCS Policlinico San Matteo Foundation, Pavia, Italy.
Giulia Maria StellaCardiothoracic and Vascular Department, Unit of Respiratory Diseases, IRCCS Policlinico San Matteo Foundation, Pavia, Italy.
Angelo Guido CorsicoCardiothoracic and Vascular Department, Unit of Respiratory Diseases, IRCCS Policlinico San Matteo Foundation, Pavia, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aim: Severe pneumonia management in the hospital setting often relies heavily on established clinical practice and physician experience. This approach has the purpose of enabling early identification of risk factors most strongly associated with severe pneumonia at the time of hospital admission. Methods: This retrospective study analyzed inpatients with pneumonia treated in a Respiratory disease unit, stratifying them into two groups-severe and non-severe pneumonia - according to the 2007 IDSA/ATS criteria, identifying differences in demographic profiles, clinical features, treatment strategies, and prognostic outcomes. Results: Out of a cohort of 302 patients, 26 (8.6%) met the criteria for severe pneumonia. A statistically significant difference was observed in the Pneumonia Severity Index (PSI > 90), recorded in 61.53% of patients with severe pneumonia compared to 41.31% in non-severe cases. The Charlson Comorbidity Index (CCI ≥ 4), indicative of lower 10-year survival due to comorbidities, was significantly more frequent in the severe group (84.61% vs. 61.23%). Microbiological analysis of bronchoalveolar lavage (BAL) showed a positivity rate of 75% in the severe group versus 35.48% in the non-severe group ( Conclusion: Timely recognition of these factors is essential to ensure optimal patient care, facilitate close monitoring of critically ill individuals, allow for prompt therapeutic escalation, and support ICU admission when needed. This analysis highlights the need for a critical reassessment of existing guidelines and underscores the value of integrating them with real-world clinical experience.

Indexed as

antibioticsbiomarkerpersonalized medicinepneumoniaventilation

Identifiers

PMID41048929
PMCPMC12488406

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.